MTA1 and breast cancer: Analysis of 1166 breast cancer patients in The Cancer Genome Atlas (TCGA) database and breast cancer case data in GEPIA showed that the FOXP3 expression level was negatively correlated with the MTA1 expression level (Figures 4C, D), consistent with our results.